Liver tissue models could unlock secrets of deadly infections
NCT ID NCT05255042
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study used leftover liver tissue from 36 adults who had surgery to create lab models of early infection. Researchers want to learn how bacteria and viruses first take hold in the liver, which could lead to new ways to prevent or treat serious bloodstream infections. The study did not test any drugs or treatments on people.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could lead to better lab models for studying how infections start in the liver, helping develop new treatments for serious infections.
- What could go wrong
- This is a small, completed tissue study, not a clinical trial testing a treatment in patients. The models may not fully replicate human infection, and findings may not translate to real-world therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UHL NHS Trust - Leicester General Hospital
Leicester, LE5 4PW, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app tame Alcohol-Related liver disease?
- Can a smarter scan make liver testing more reliable?
- A new Anti-Rejection strategy may spare kidney function after liver transplant
- Can a quick MRI scan reveal what a healthy Child's liver looks like?
- Blood test and AI could spot liver cancer early, saving lives
- Food flavors on the breath may reveal hidden liver disease